Novel Biomarkers and the Future Potential of Biomarkers in Inflammatory Bowel Disease
Table 2
(a) Use of novel fecal markers to assess disease activity (inactive versus active) in IBD. (b) Correlation of novel fecal markers to assess severity in IBD.
Age: A: adult; P: paediatric, values are median; Pop.: type of population; N: number of patients; NS: nonsignificant; square brackets []: number of patients, r: correlation coefficient; CD: Crohn’s disease; UC: ulcerative colitis; IOIBD: International Organization for the Study of Inflammatory Bowel Diseases score; PCDAI: paediatric Crohn’s disease activity index; PUCAI: paediatric ulcerative colitis activity index; SES-CD: simple endoscopic score for Crohn’s disease.